Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): A pilot cluster randomized trial

Implementation Science

Volumn 8, Issue 1, 2013, Pages

  Pai, Menaka ^a,b   Lloyd, Nancy S ^a   Cheng, Ji ^a,c   Thabane, Lehana ^a,c,d   Spencer, Frederick A ^a   Cook, Deborah J ^a   Haynes, R Brian ^a   Schünemann, Holger J ^a   Douketis, James D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

^d CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

Anticoagulants; Cluster randomization; Medical patients; Standard orders; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MEDICAL ERROR; MEDICAL RECORD; MIDDLE AGED; MULTICENTER STUDY; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL; STATISTICS; UNNECESSARY PROCEDURE; VENOUS THROMBOEMBOLISM; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; EPIDEMIOLOGIC METHODS; FEMALE; GUIDELINE ADHERENCE; HEPARIN; HOSPITALIZATION; HUMANS; MALE; MEDICAL ERRORS; MEDICAL RECORDS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL PRACTICE; UNNECESSARY PROCEDURES; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

MLCS; MLOWN;

EID: 84871706685     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/1748-5908-8-1     Document Type: Article

References (34)

1. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991, 151:933-938. 10.1001/archinte.1991.00400050081016, 2025141.
2. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004, 93:259-262. 10.1016/j.amjcard.2003.09.057, 14715365.
3. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002, 162:1245-1248. 10.1001/archinte.162.11.1245, 12038942.
4. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:381S-453S. 10.1378/chest.08-0656, 18574271.
5. Shojania KG, Duncan BW, McDonald KM, Wachter RM. Making Health Care Safer: A critical analysis of patient safety practices Evidence Report/Technology Assessment, No. 43. 2009. Agency for Healthcare Research and Quality Research and Quality. 22-12-2009. http://www.ahrq.gov/clinic/ptsafety/ (accessed 1 Jun 2011).
6. Maynard GA, Stein J. Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement. Agency for Healthcare Research and Quality http://www.ahrq.gov/qual/vtguide/ (accessed 1 Jun 2011).
7. National Quality Forum National Voluntary Consensus Standards for Prevention and Care of Venous Thromboembolism: Policy, Preferred Practices, and Initial Performance Measures. National Quality Forum http://www.qualityforum.org/Home.aspx (accessed 1 Jun 2011), National Quality Forum.
8. The Joint Commission Specifications Manual for National Hospital Inpatient Quality Measures. The Joint Commission http://www.jointcommission.org/specifications_manual_for_national_hospital_inpatient_quality_measures/ (accessed 1 Jun 2011), The Joint Commission.
9. Dentali F, Douketis JD, Gianni M, et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007, 146:278-288.
10. Amin A, Stemkowski S, Lin J, et al. Thromboprophylaxis rates in US medical centers: success or failure?. J Thromb Haemost 2007, 5:1610-1616. 10.1111/j.1538-7836.2007.02650.x, 17663733.
11. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest 2001, 120:1964-1971. 10.1378/chest.120.6.1964, 11742929.
12. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008, 371:387-394. 10.1016/S0140-6736(08)60202-0, 18242412.
13. Kahn SR, Panju A, Geerts W, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 2007, 119:145-155. 10.1016/j.thromres.2006.01.011, 16516275.
14. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007, 132:936-945. 10.1378/chest.06-2993, 17573514.
15. Durieux P, Nizard R, Ravaud P, et al. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA 2000, 283:2816-2821. 10.1001/jama.283.21.2816, 10838650.
16. Galanter WL, Thambi M, Rosencranz H, et al. Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital. Am J Health Syst Pharm 2010, 67:1265-1273. 10.2146/ajhp090575, 20651317.
17. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005, 352:969-977. 10.1056/NEJMoa041533, 15758007.
18. Piazza G, Rosenbaum EJ, Pendergast W, et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation 2009, 119:2196-2201. 10.1161/CIRCULATIONAHA.108.841197, 2901546, 19364975.
19. Maynard GA, Morris TA, Jenkins IH, et al. Optimizing prevention of hospital-acquired (HA) venous thromboembolism (VTE): Prospective validation of a VTE risk assessment model (RAM). J Hosp Med 2009, 5:10-18.
20. McMullin J, Cook D, Griffith L, et al. Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study. Crit Care Med 2006, 34:694-699. 10.1097/01.CCM.0000201886.84135.CB, 16505655.
21. Cook D, Tkaczyk A, Lutz K, et al. Thromboprophylaxis for hospitalized medical patients: a multicenter qualitative study. J Hosp Med 2009, 4:269-275. 10.1002/jhm.461, 19504488.
22. Lloyd NS, Douketis JD, Cheng J, et al. Barriers and potential solutions toward optimal prophylaxis against deep vein thrombosis for hospitalized medical patients: a survey of health care professionals. J Hosp Med 2011, Oct 28. [Epub ahead of print].
23. Amin AN, Deitelzweig SB. Optimizing the prevention of venous thromboembolism: recent quality initiatives and strategies to drive improvement. Jt Comm J Qual Patient Saf 2009, 35:558-564.
24. Michota FA. Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process. J Gen Intern Med 2007, 22:1762-1770. 10.1007/s11606-007-0369-z, 2219822, 17891516.
25. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005, 241:397-415. 10.1097/01.sla.0000154120.96169.99, 1356978, 15729062.
26. Arnold DM, Burns KE, Adhikari NK, et al. The design and interpretation of pilot trials in clinical research in critical care. Crit Care Med 2009, 37(1 Suppl):S69-74.
27. Thabane L, Ma J, Chu R, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010, 10:1. 10.1186/1471-2288-10-1, 2824145, 20053272.
28. Campbell MK, Grimshaw JM, Elbourne DR. Intracluster correlation coefficients in cluster randomized trials: empirical insights into how should they be reported. BMC Med Res Methodol 2004, 4:9. 10.1186/1471-2288-4-9, 415547, 15115554.
29. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 2006, 129:174-181. 10.1378/chest.129.1.174, 16424429.
30. Schunemann HJ, Cook D, Guyatt G, et al. Methodology for antithrombotic and thrombolytic therapy guideline development: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:113S-122S. 10.1378/chest.08-0666, 18574261.
31. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 2005, 293:1223-1238. 10.1001/jama.293.10.1223, 15755945.
32. Ferlie EB, Shortell SM. Improving the quality of health care in the United Kingdom and the United States: a framework for change. Milbank Q 2001, 79:281-315. 10.1111/1468-0009.00206, 2751188, 11439467.
33. Grimshaw J, Eccles M, Tetroe J. Implementing clinical guidelines: current evidence and future implications. J Contin Educ Health Prof 2004, 24:S31-S37. 10.1002/chp.1340240506, 15712775.
34. Walker AE, Grimshaw J, Johnston M, et al. PRIME - PRocess modelling in ImpleMEntation research: selecting a theoretical basis for interventions to change clinical practice. BMC Health Serv Res 2003, 3:22. 10.1186/1472-6963-3-22, 317340, 14683530.